Dr. Daniel Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of neurology, psychiatry and human genetics at the UCLA School of Medicine, and the Senior Associate Dean and Associate Vice Chancellor of Precision Medicine in the UCLA Health System and David Geffen School of Medicine. He is director of the Neurogenetics Program and the Center for Autism Research and Treatment (CART) and co-director of the Center for Neurobehavioral Genetics in the Semel Institute at UCLA. Dr. Geschwind obtained an A.B. in chemistry and psychology (modified) at Dartmouth College, followed by 2 years as a research associate at the Boston Consulting Group. He subsequently obtained his M.D./Ph.D (neurobiology). at Yale School of Medicine (AOA) prior to completing his internship, residency (Neurology), and postdoctoral fellowship at UCLA, after which he joined the faculty, founding the neurogenetics program within the department of Neurology in 1997. Dr. Geschwind’s laboratory has focused primarily on developing a mechanistic understanding of autism and neurodegenerative diseases. The laboratory combines genetic, genomic and bio-informatic approaches with basic neurobiological investigation in model systems and human brain. These approaches relie heavily on computational and bioinformatic methods in addition to wet laboratory experimentation. The lab has pioneered the application of gene expression and network methods in neurologic and psychiatric disease, working in collaboration with dozens of other laboratories to connect molecular pathways to nervous system function. The over-arching goal is to develop new therapeutics for nervous system disorders for which disease-altering therapies are not currently available. Dr. Geschwind is also a strong advocate for data and biomaterial sharing, having provided scientific leadership for the Autism Genetic Resource Exchange (AGRE), a resource for family studies of autism. He serves or has served on numerous scientific advisory boards, including as the co-chair of the Genetics section for the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Scientific Advisory Board for the Allen Institute for Brain Science, the NIMH Advisory Council and the NIH Council of Councils. He has published over 390 papers and serves on the editorial boards of Biological Psychiatry, Cell, Current Opinion in Genetics & development, Human Molecular Genetics, Neurobiology of Disease, Neuron and Science. He received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2004, an NIMH MERIT Award, the Scientific Service Award from Autism Speaks in 2007, the Ruane Prize for Child and Adolescent Psychiatric Research from the Brain and Behavior foundation in 2012, the Taking on Tomorrow Innovation Award (Research/Scientific Breakthrough in Autism) -Boston Children’s Hospital in 2013 and the Amgen early innovators award in 2018. He is a member of the American Academy of Physicians, and is an elected member of the National Academy of Medicine, USA.